The activity of LY146032, a new lipopeptide antibiotic, was compared in vitro with those of vancomycin, oxacillin, and ampicillin against 261 staphylococcal and 154 streptococcal isolates. The MICs of LY146032 and vancomycin were similar, but the bactericidal activity and killing kinetics of LY146032 were more pronounced.
No takes yet. Share an insight, caveat, or question.
L. Verbist (1987) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: